D'Aquila RT - Search Results

1

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.

Brown AJ, Precious HM, Whitcomb JM, Wong JK, Quigg M, Huang W, Daar ES, D'Aquila RT, Keiser PH, Connick E, Hellmann NS, Petropoulos CJ, Richman DD, Little SJ. Brown AJ, et al. J Virol. 2000 Nov;74(22):10269-73. doi: 10.1128/jvi.74.22.10269-10273.2000. J Virol. 2000. PMID: 11044070 Free PMC article.

2

Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy.

Brown AJ, Günthard HF, Wong JK, D'Aquila RT, Johnson VA, Kuritzkes DR, Richman DD. Brown AJ, et al. J Infect Dis. 1999 Oct;180(4):1043-9. doi: 10.1086/315017. J Infect Dis. 1999. PMID: 10479129 Clinical Trial.

3

Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD, Richman DD. Little SJ, et al. JAMA. 1999 Sep 22-29;282(12):1142-9. doi: 10.1001/jama.282.12.1142. JAMA. 1999. PMID: 10501117

4

Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy.

Precious HM, Günthard HF, Wong JK, D'Aquila RT, Johnson VA, Kuritzkes DR, Richman DD, Leigh Brown AJ. Precious HM, et al. AIDS. 2000 Jan 7;14(1):31-6. doi: 10.1097/00002030-200001070-00004. AIDS. 2000. PMID: 10714565 Clinical Trial.

5

Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol.

Günthard HF, Leigh-Brown AJ, D'Aquila RT, Johnson VA, Kuritzkes DR, Richman DD, Wong JK. Günthard HF, et al. Virology. 1999 Jun 20;259(1):154-65. doi: 10.1006/viro.1999.9774. Virology. 1999. PMID: 10364500 Free article.

6

Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.

Hanna GJ, Johnson VA, Kuritzkes DR, Richman DD, Martinez-Picado J, Sutton L, Hazelwood JD, D'Aquila RT. Hanna GJ, et al. J Clin Microbiol. 2000 Jul;38(7):2715-21. doi: 10.1128/JCM.38.7.2715-2721.2000. J Clin Microbiol. 2000. PMID: 10878069 Free PMC article. Clinical Trial.

7

Antiretroviral resistance during successful therapy of HIV type 1 infection.

Martinez-Picado J, DePasquale MP, Kartsonis N, Hanna GJ, Wong J, Finzi D, Rosenberg E, Gunthard HF, Sutton L, Savara A, Petropoulos CJ, Hellmann N, Walker BD, Richman DD, Siliciano R, D'Aquila RT. Martinez-Picado J, et al. Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10948-53. doi: 10.1073/pnas.97.20.10948. Proc Natl Acad Sci U S A. 2000. PMID: 11005867 Free PMC article.

8

Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine.

Hanna GJ, Johnson VA, Kuritzkes DR, Richman DD, Brown AJ, Savara AV, Hazelwood JD, D'Aquila RT. Hanna GJ, et al. J Infect Dis. 2000 Mar;181(3):904-11. doi: 10.1086/315329. J Infect Dis. 2000. PMID: 10720511 Clinical Trial.

9

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.

Bacheler L, Jeffrey S, Hanna G, D'Aquila R, Wallace L, Logue K, Cordova B, Hertogs K, Larder B, Buckery R, Baker D, Gallagher K, Scarnati H, Tritch R, Rizzo C. Bacheler L, et al. J Virol. 2001 Jun;75(11):4999-5008. doi: 10.1128/JVI.75.11.4999-5008.2001. J Virol. 2001. PMID: 11333879 Free PMC article.

10

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group.

Japour AJ, Welles S, D'Aquila RT, Johnson VA, Richman DD, Coombs RW, Reichelderfer PS, Kahn JO, Crumpacker CS, Kuritzkes DR. Japour AJ, et al. J Infect Dis. 1995 May;171(5):1172-9. doi: 10.1093/infdis/171.5.1172. J Infect Dis. 1995. PMID: 7538548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters